AVCNF News and Press, Avicanna Inc From 08/14/25

2025-08-14 12:05:28 ET More on Avicanna Financial information for Avicanna Inc. Read the full article on Seeking Alpha For further details see: Avicanna reports Q2 results

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products...

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” o...

TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...

TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products...

2025-05-15 10:25:11 ET More on Avicanna Inc. Avicanna Inc. (AVCNF) Q4 2024 Earnings Call Transcript Financial information for Avicanna Inc. Read the full article on Seeking Alpha For further details see: Avicanna reports Q1 results

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is p...

2025-04-22 23:38:43 ET Avicanna Inc. (AVCNF) Q4 2024 Earnings Call April 22, 2025 08:30 ET Company Participants Aras Azadian - Chief Executive Officer Phil Cardella - Chief Financial Officer Conference Call Participants Barbara Hickson - Private Investor ...

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based produc...